| mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.35 |
3e-25 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
1e-20 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.25 |
6e-06 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
7e-06 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.2 |
9e-06 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-05 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |